Bug of the Month helps educate readers about existing and emerging pathogens of clinical importance in healthcare facilities today. Each column explores the Bug of the Month's etiology, the infections it can cause, the modes of transmission, and ways to fight its spread.
Previous infection with either Zika virus or dengue virus has no apparent effect on the clinical course of subsequent infection with the other virus, according to a study published August 1 in the open-access journal PLOS Pathogens by David O'Connor of the University of Wisconsin-Madison, and colleagues.
Comparing a living cell to a virus is a bit like comparing the Sistine Chapel to a backyard dog house. Lacking the intricate machinery of living cells, viruses represent biology stripped down to an extreme level. They are the true minimalists of the biological world.
The World Health Organization’s declaration that the year-long Ebola crisis is a Public Health Emergency of International Concern (PHEIC) is hoped to raise much-needed awareness and resources for preparedness and control efforts across the region, says the Infectious Diseases Society of America (IDSA).
As cases of Ebola continue to increase in the eastern region of the Democratic Republic of the Congo (DRC), and travel-associated cases have been reported in neighboring Uganda, CDC fully supports the decision by the International Health
A team of researchers from the SingHealth Duke-NUS Academic Medicine Centre's Viral Research and Experimental Medicine Centre (ViREMiCS) found that immune cells undergoing stress and an altered metabolism are the reasons why some individuals become sick from viral infections while others do not, when exposed to the same virus.
In 2014, a virus called crAssphage that infects bacteria was discovered as part of the body’s intestinal environment. Now, a new study has investigated the origin and evolution of this virus, which may have coevolved with human lineage.
EPFL scientists have created the first world map of regions with the highest prevalence of the hepatitis E virus (HEV).
New research by the Centers for Disease Control and Prevention (CDC) shows two investigational Ebola treatments being used in the ongoing outbreak in eastern Democratic Republic of the Congo (DRC) are effective in laboratory studies.
A new protein called KHNYN has been identified as a missing piece in a natural antiviral system that kills viruses by targeting a specific pattern in viral genomes, according to new findings published today in eLife.